| 44.77 BATS BZX Real-Time Price As of 12:40pm ET |  -0.55 / -1.21%Today’s Change | 44.30 Today|||52-Week Range 63.69 | -13.87% Year-to-Date |
| Previous close | 45.32 |
| Today’s open | 45.50 |
| Day’s range | 44.73 - 45.53 |
| Volume | 6,045,364 |
| Average volume (3 months) | 18,338,753 |
| Market cap | $74.4B |
| Earnings growth (last year) | +393.92% |
| Earnings growth (this year) | +5.13% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 14.9 |
| Price/Sales | 3.77 |
| Price/Book | 5.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene | -0.55 | -0.59% |
| NVONovo Nordisk | -0.15 | -0.31% |
| TAKTakeda Pharmaceutica... | -0.03 | -0.14% |
| AZNAstraZeneca | +0.22 | +0.57% |
| Next reporting date | April 25, 2019 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
